A Smo/Gli Multitarget Hedgehog Pathway Inhibitor Impairs Tumor Growth

Pharmacological Hedgehog (Hh) pathway inhibition has emerged as a valuable anticancer strategy. A number of small molecules able to block the pathway at the upstream receptor Smoothened (Smo) or the downstream effector glioma-associated oncogene 1 (Gli1) has been designed and developed. In a recent...

Descripción completa

Detalles Bibliográficos
Autores principales: Lospinoso Severini, Ludovica, Quaglio, Deborah, Basili, Irene, Ghirga, Francesca, Bufalieri, Francesca, Caimano, Miriam, Balducci, Silvia, Moretti, Marta, Romeo, Isabella, Loricchio, Elena, Maroder, Marella, Botta, Bruno, Mori, Mattia, Infante, Paola, Di Marcotullio, Lucia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826940/
https://www.ncbi.nlm.nih.gov/pubmed/31601026
http://dx.doi.org/10.3390/cancers11101518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826940/
https://www.ncbi.nlm.nih.gov/pubmed/31601026
http://dx.doi.org/10.3390/cancers11101518

Ejemplares similares